Bone and mineral disorders among Saudi diabetics

Muhammad Mahmood Akhtar, Abdulaziz Saad Alghamdi, Abdulrahman Mohammed Alshehri, Hussain Zaki Alfaraj, Abdullah Mohammed Alshamrani, Anoud Abdulrazzag Althagafi, Elaf Abdulqader Bahanshel, Muataz Abdulmoghni Aljunaid, Mohammad Abbas AlAjlani, Mohammed Ali Al-Khathami, Mohammed Mana Alqahtani


Increasing bone and mineral changes which caused by both diabetes type 1 and type 2 can raise fracture risks for a period of time during illness and low blood sugar levels. The connection between diabetes and bone fragility is further complicated by the variable effects on the skeleton by various diabetic medications. Diabetic patients are at a higher risk of bone and mineral density alterations, osteoporosis and fragility fractures. Diabetic patients are often susceptible to develop various conditions due to malnutrition, uncontrolled blood sugar and lack of proper follow up regiment. Diabetics should be tested for osteoporosis risk and given effective prevention strategies. Preventing osteoporosis would require interventions such as sufficient vitamin D and calcium intake, physical exercise and exposure to sunlight.


Diabetes, Bone and mineral density, Saudi Arabia, Complications

Full Text:



Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporo Int. 2018;29(12):2585-96.

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. Diabet Res Clin Pract. 2019;157:107843.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.

Isidro ML, Ruano B. Bone disease in diabetes. Current Diabet Rev. 2010;6(3):144-55.

Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clinic Endocrinol Metabol. 2007;92(6):2017-29.

Young VR. Trace element biology: the knowledge base and its application for the nutrition of individuals and populations. J Nutrit. 2003;133:1581-7.

Wang W, Zhang X, Zheng J, Yang J. High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway. Molecul Cell Biochem. 2010;338(1-2):115-22.

Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Y, et al. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clinic Endocrinol Metabol. 1997;82(9):2915-20.

Vianna AGD, Sanches CP, Barreto FC. Review article: effects of type 2 diabetes therapies on bone metabolism. Diabetol Metabol Syndr. 2017;9(1):75.

Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int. 2009;84(1):45-55.

Farr JN, Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone. 2016;82:28-34.

Strotmeyer ES, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS. Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care. 2006;29(2):306-11.

Campos PMM, López-Ibarra PJ, Escobar-Jiménez F, Serrano Pardo MD, García-Cervigón AG. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteopor Int. 2000;11(5):455-9.

Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus. Saudi Med J. 2004;25(10):1423-7.

Al-Homood IA, Sheshah I, Mohammed AGA, Gasim GI. The prevalence and risk factors of osteoporosis among a Saudi female diabetic population. Open Acc Maced J Med Sci. 2017;5(2):177-81.

Al-Hariri M. Sweet bones: the pathogenesis of bone alteration in diabetes. J Diabet Res. 2016:6969040.

Khoshhal KI, Sheweita SA, Al-Maghamsi MS, Habeb AM. Does type 1 diabetes mellitus affect bone quality in prepubertal children? J Taibah Univ Med Sci. 2015;10(3):300-5.

Schwartz AV, Ewing SK, Porzig AM, McCulloch CE, Resnick HE, Hillier TA, et al. Diabetes and change in bone mineral density at the hip, calcaneus, spine, and radius in older women. Front Endocrinol. 2013;4:62.

Dubey P, Thakur V, Chattopadhyay M. Role of minerals and trace elements in diabetes and insulin resistance. Nutrients. 2020;12(6):1864.

Wang X, Pei Y. Correlation of bone mineral density with disease duration and body mass in elder men with type 2 diabetes mellitus. Chin J Tissue Engine Res. 2007;27(2):190-7.

Raj S, Baiju S, Vijayan R, Rajan G. Association between Bone Mineral Density and Type 2 Diabetes Mellitus-an original. Brit J Res. 2014;1(2):63-7.

Farid SM, Abulfaraj TG. Trace mineral status related to levels of glycated hemoglobin of type 2 diabetic subjects in Jeddah, Saudi Arabia. Med J Islamic World Aca Sci. 2013;109(892):1-10.

DiSilvestro RA. Zinc in relation to diabetes and oxidative disease. J Nutrit. 2000;130(5):1509-11.

Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, et al. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biolog Trace Elem Res. 2008;122(1):1-18.

Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28(5):1175-81.

Mellits D. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28(37):5-10.

Hariri AF, Almatrafi MN, Zamka AB, Babaker AS, Fallatah M, Althouwaibi OH, et al. Relationship between body mass index and T-Scores of bone mineral density in the hip and spine regions among older adults with diabetes: a retrospective review. J Obesit. 2019:9827403.

Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305(21):2184-92.

Schacter GI, Leslie WD. DXA-based measurements in diabetes: can they predict fracture risk? Calcified Tissue Int. 2017;100(2):150-64.

Alhumaidi M, Agha A, Dewish M. Vitamin D deficiency in patients with type-2 diabetes mellitus in southern region of Saudi Arabia. Maedica. 2013;8(3):231-6.

Kota S, Jammula S, Kota S, Meher L, Modi K. Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density. Ind J Orthopaed. 2013;47(4):402-7.

Sultan E, Taha I, Saber LM. Altered bone metabolic markers in type 2 diabetes mellitus: impact of glycemic control. J Taibah Univer Med Sci. 2008;3(2):104-16.